People News

Share this article:

Marketing research firm IMS Health has announced the election of Bradley Sheares to its board of directors. Shears was most recently CEO of Reliant Pharmaceuticals. Prior to Reliant, Sheares was president of Merck's US human health division.

 

ANI Pharmaceuticals, a specialty generic pharmaceuticals manufacturer, has announced the appointment of Arthur Przbyl as CEO. Przybyl, previously president and CEO of Akorn pharmaceuticals, will also join ANI's board of directors. Przybyl replaces Tom Anderson, ANI's founding CEO, who is leaving to pursue other opportunities.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters